The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy (Q41036251)
Jump to navigation
Jump to search
scientific article published on 11 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy |
scientific article published on 11 July 2017 |
Statements
1 reference
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy (English)
1 reference
Marc-Eric Halatsch
1 reference
Richard E Kast
1 reference
Nicolas Skuli
1 reference
Samuel Cos
1 reference
Georg Karpel-Massler
1 reference
Yusuke Shiozawa
1 reference
Ran Goshen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference